About us

INAGEN’s core focus
INAGEN has created a novel method of developing new forms of therapies against viral diseases. The technology utilizes a “self targeting capability”, which takes place in the natural defense mechanism of the specific disease, to target and kill infected cells. The platform technology can be utilized to target numerous infectious diseases.

Mission
The INAGEN mission is to exploit the potential of our platform techniology to develop therapeutics for the treatment of selected types of viral diseases.

Our Strategy
INAGEN’s business strategy is to utilize our proprietary technology in the area of anti-viral and anti-parasitic drug development, add new intellectual properties and in license, acquire or co-develop technologies necessary for antigen therapy.

INAGEN collaborates with world leading academic groups working in the field. This provides INAGEN with an exclusive position regarding novel inventions. At the same time, INAGEN is actively searching for new and stronger elements which can be integrated into future products, thus strengthening IPR. The company will be carrying out all lead development and pre-clinical molecular and cell testing internally, while specific animal testing is out-sourced. All these tests will serve as the foundation for partnering opportunities and clinical testing.